[HTML][HTML] Targeting p53 pathways: mechanisms, structures, and advances in therapy

H Wang, M Guo, H Wei, Y Chen - Signal transduction and targeted …, 2023 - nature.com
The TP53 tumor suppressor is the most frequently altered gene in human cancers, and has
been a major focus of oncology research. The p53 protein is a transcription factor that can …

[HTML][HTML] Targeting p53 for the treatment of cancer

MJ Duffy, NC Synnott, S O'Grady, J Crown - Seminars in cancer biology, 2022 - Elsevier
Dysfunction of the TP53 (p53) gene occurs in most if not all human malignancies. Two
principal mechanisms are responsible for this dysfunction; mutation and downregulation of …

Targeting biomolecular condensation and protein aggregation against cancer

JL Silva, D Foguel, VF Ferreira, TCRG Vieira… - Chemical …, 2023 - ACS Publications
Biomolecular condensates, membrane-less entities arising from liquid–liquid phase
separation, hold dichotomous roles in health and disease. Alongside their physiological …

[HTML][HTML] The role of p53 signaling in colorectal cancer

MC Liebl, TG Hofmann - Cancers, 2021 - mdpi.com
Simple Summary The transcription factor p53 is a crucial tumor suppressor that regulates
diverse cellular responses to protect against cancer development. Deactivating p53 …

Gain-of-function mutant p53 in cancer progression and therapy

C Zhang, J Liu, D Xu, T Zhang, W Hu… - Journal of molecular …, 2020 - academic.oup.com
Abstract p53 is a key tumor suppressor, and loss of p53 function is frequently a prerequisite
for cancer development. The p53 gene is the most frequently mutated gene in human …

[HTML][HTML] Putting p53 in context

ER Kastenhuber, SW Lowe - Cell, 2017 - cell.com
TP53 is the most frequently mutated gene in human cancer. Functionally, p53 is activated by
a host of stress stimuli and, in turn, governs an exquisitely complex anti-proliferative …

[HTML][HTML] Mutant p53 in cancer progression and targeted therapies

G Zhu, C Pan, JX Bei, B Li, C Liang, Y Xu, X Fu - Frontiers in oncology, 2020 - frontiersin.org
TP53 is the most frequently mutated tumor suppressor gene in human cancer. The majority
of mutations of p53 are missense mutations, leading to the expression of the full length p53 …

[HTML][HTML] Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246

T Cooks, IS Pateras, LM Jenkins, KM Patel… - Nature …, 2018 - nature.com
Abstract TP53 mutants (mutp53) are involved in the pathogenesis of most human cancers.
Specific mutp53 proteins gain oncogenic functions (GOFs) distinct from the tumor …

[HTML][HTML] The p53 pathway in glioblastoma

Y Zhang, C Dube, M Gibert Jr, N Cruickshanks, B Wang… - Cancers, 2018 - mdpi.com
The tumor suppressor and transcription factor p53 plays critical roles in tumor prevention by
orchestrating a wide variety of cellular responses, including damaged cell apoptosis …

[HTML][HTML] Role of p53 in breast cancer progression: An insight into p53 targeted therapy

C Marvalim, A Datta, SC Lee - Theranostics, 2023 - ncbi.nlm.nih.gov
The transcription factor p53 is an important regulator of a multitude of cellular processes. In
the presence of genotoxic stress, p53 is activated to facilitate DNA repair, cell cycle arrest …